Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response.
D000208:Acute Disease; D000328:Adult; D001772:Blood Cell Count; D001792:Blood Platelets; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007263:Infusions, Parenteral; D007938:Leukemia / Q000097:blood / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009365:Neoplasm Regression, Spontaneous; D012075:Remission, Spontaneous; D012737:Sex Factors; D013997:Time Factors
D003561:Cytarabine